Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | -7.57%168.13M | 4.30%771.47M | -45.70%181.89M | 3.94%739.66M | -38.39%335M | -37.34%711.61M | 3.09%543.75M | 62.06%1.14B | 44.87%527.44M | -70.30%700.73M |
| Operating income | -7.57%168.13M | 4.30%771.47M | -45.70%181.89M | 3.94%739.66M | -38.39%335M | -37.34%711.61M | 3.09%543.75M | 62.06%1.14B | 44.87%527.44M | -70.30%700.73M |
| Cost of sales | 18.64%-214.64M | 3.08%-675.78M | 21.58%-263.81M | 33.40%-697.26M | 53.86%-336.41M | 30.52%-1.05B | -4.45%-729.04M | -28.93%-1.51B | -17.94%-698M | 34.56%-1.17B |
| Operating expenses | 18.64%-214.64M | 3.08%-675.78M | 21.58%-263.81M | 33.40%-697.26M | 53.86%-336.41M | 30.52%-1.05B | -4.45%-729.04M | -28.93%-1.51B | -17.94%-698M | 34.56%-1.17B |
| Gross profit | 43.23%-46.51M | 125.67%95.69M | -5,734.97%-81.92M | 112.64%42.4M | 99.24%-1.4M | 9.67%-335.36M | -8.64%-185.29M | 20.67%-371.25M | 25.10%-170.56M | -181.55%-467.98M |
| Selling expenses | -14.99%-5.41M | -11.24%-113.04M | 89.23%-4.7M | -26.79%-101.61M | 30.10%-43.67M | ---80.14M | -5.69%-62.47M | ---- | -29.76%-59.11M | ---- |
| Administrative expenses | -19.46%-66.8M | 26.97%-152.37M | 35.35%-55.92M | 13.48%-208.64M | 37.06%-86.5M | ---241.15M | 9.64%-137.44M | ---- | 17.88%-152.1M | ---- |
| Impairment and provision | -4,103,919.35%-1.27B | -272,752.90%-376.26M | -116.85%-31K | 108.67%138K | 118.70%184K | ---1.59M | 99.60%-984K | ---- | -19,936.04%-248.74M | ---- |
| -Other impairment is provision | -4,103,919.35%-1.27B | -272,752.90%-376.26M | -116.85%-31K | 108.67%138K | 118.70%184K | ---1.59M | 99.60%-984K | ---- | -19,936.04%-248.74M | ---- |
| Operating interest expense | ---- | ---- | ---- | ---- | ---- | ---- | -66.02%-49.13M | ---- | 32.74%-29.59M | ---- |
| Special items of operating profit | 121.01%1.54M | -381.05%-5.33M | -219.02%-7.35M | -105.58%-1.11M | 193.49%6.17M | -5.50%19.85M | -133.66%-6.6M | -52.32%21.01M | 19.94%19.62M | -53.76%44.06M |
| Operating profit | -826.75%-1.39B | -105.09%-551.31M | -19.74%-149.92M | 57.89%-268.82M | 71.67%-125.21M | -82.27%-638.39M | 31.00%-441.92M | 17.38%-350.25M | -32.09%-640.48M | -163.36%-423.92M |
| Financing cost | 20.89%-73.7M | 6.12%-189.79M | -2.74%-93.16M | -83.83%-202.16M | ---90.67M | -68.15%-109.97M | ---- | 49.14%-65.4M | ---- | -36.97%-128.58M |
| Share of profits of associates | ---- | ---- | ---- | ---- | ---- | 75.11%-7.08M | 39.43%-7.08M | -11.00%-28.46M | -34.70%-11.7M | -529.67%-25.64M |
| Special items of earning before tax | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 47.61%-673.46M | ---- | -80.90%-1.29B |
| Earning before tax | -501.90%-1.46B | -57.35%-741.1M | -12.60%-243.08M | 37.66%-470.98M | 51.92%-215.89M | 32.40%-755.44M | 31.15%-449M | 40.03%-1.12B | -32.14%-652.18M | -1,237.00%-1.86B |
| Tax | 927.63%33.33M | -89.68%43.44M | 20.29%3.24M | 184.07%421.1M | 107.39%2.7M | 303.42%148.24M | -0.11%-36.5M | 20.49%-72.87M | 35.61%-36.46M | -80.14%-91.65M |
| After-tax profit from continuing operations | -496.15%-1.43B | -1,298.62%-697.66M | -12.50%-239.84M | 91.79%-49.88M | 56.09%-213.19M | 48.99%-607.21M | 29.50%-485.51M | 39.11%-1.19B | -25.17%-688.64M | -927.66%-1.96B |
| After-tax profit from non-continuing business | -93.10%8.97M | 66.89%75.04M | 323.30%129.91M | --44.96M | --30.69M | ---- | ---- | ---- | ---- | ---- |
| Earning after tax | -1,192.54%-1.42B | -12,552.45%-622.63M | 39.77%-109.93M | 99.19%-4.92M | 62.41%-182.5M | 48.99%-607.21M | 29.50%-485.51M | 39.11%-1.19B | -25.17%-688.64M | -927.66%-1.96B |
| Profit attributable to shareholders | -1,192.54%-1.42B | -12,552.45%-622.63M | 39.77%-109.93M | 99.19%-4.92M | 62.41%-182.5M | 48.99%-607.21M | 29.50%-485.51M | 39.11%-1.19B | -25.17%-688.64M | -927.66%-1.96B |
| Basic earnings per share | -1,192.27%-2.2912 | -12,450.00%-0.1004 | -503.06%-0.1773 | 99.18%-0.0008 | 62.45%-0.0294 | 49.01%-0.0979 | 29.46%-0.0783 | 39.05%-0.192 | -24.72%-0.111 | -950.00%-0.315 |
| Diluted earnings per share | ||||||||||
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion |
| Auditor | -- | -- | -- | Ernst & Young Accounting Firm | -- | Ernst & Young Accounting Firm | -- | Ernst & Young Accounting Firm | -- | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.